Standard screening methods underreport AAV-mediated transduction and gene editing

被引:0
|
作者
Jonathan F. Lang
Sushila A. Toulmin
Kasey L. Brida
Laurence C. Eisenlohr
Beverly L. Davidson
机构
[1] The Children’s Hospital of Philadelphia,The Department of Pathology and Laboratory Medicine, Perelman School of Medicine
[2] University of Pennsylvania,undefined
来源
Nature Communications | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Conventional methods to discern adeno-associated virus (AAV) vector transduction patterns are based on high, stable expression of a reporter gene. As a consequence, conventionally described tropisms omit cell types that undergo transient transduction, or have low but undetectable levels of reporter expression. This creates a blind spot for AAV-based genome editing applications because only minimal transgene expression is required for activity. Here, we use editing-reporter mice to fill this void. Our approach sensitively captures both high and low transgene expression from AAV vectors. Using AAV8 and other serotypes, we demonstrate the superiority of the approach in a side-by-side comparison with traditional methods, demonstrate numerous, previously unknown sites of AAV targeting, and better predict the gene editing footprint after AAV-CRISPR delivery. We anticipate that this system, which captures the full spectrum of transduction patterns from AAV vectors in vivo, will be foundational to current and emerging AAV technologies.
引用
收藏
相关论文
共 50 条
  • [21] AAV-Mediated Gene Therapy for Atherosclerosis
    Lehrke, Michael
    Lebherz, Corinna
    CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (09)
  • [22] THE EFFECTS OF SEROTYPES AND ROUTE OF ADMINISTRATION ON TRANSDUCTION EFFICIENCY FOR AAV-MEDIATED GENE DELIVERY TO THE CNS
    Tamrazian, E.
    Benn, S.
    O'Riordan, C.
    Brown, R. H., Jr.
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (03): : 72 - 81
  • [23] AAV-mediated FOXG1 gene editing in human Rett primary cells
    Susanna Croci
    Miriam Lucia Carriero
    Katia Capitani
    Sergio Daga
    Francesco Donati
    Filomena Tiziana Papa
    Elisa Frullanti
    Diego Lopergolo
    Vittoria Lamacchia
    Rossella Tita
    Annarita Giliberti
    Elisa Benetti
    Francesca Niccheri
    Simone Furini
    Caterina Lo Rizzo
    Silvestro Giovanni Conticello
    Alessandra Renieri
    Ilaria Meloni
    European Journal of Human Genetics, 2020, 28 : 1446 - 1458
  • [24] AAV-mediated FOXG1 gene editing in human Rett primary cells
    Croci, Susanna
    Carriero, Miriam Lucia
    Capitani, Katia
    Daga, Sergio
    Donati, Francesco
    Papa, Filomena Tiziana
    Frullanti, Elisa
    Lopergolo, Diego
    Lamacchia, Vittoria
    Tita, Rossella
    Giliberti, Annarita
    Benetti, Elisa
    Niccheri, Francesca
    Furini, Simone
    Lo Rizzo, Caterina
    Conticello, Silvestro Giovanni
    Renieri, Alessandra
    Meloni, Ilaria
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (10) : 1446 - 1458
  • [25] Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing
    Hill, Victoria K.
    Kim, Jung-Sik
    James, C. David
    Waldman, Todd
    PLOS ONE, 2017, 12 (05):
  • [26] PRECISION BRAIN TUMOR THERAPY BY AAV-MEDIATED ONCOGENE EDITING
    von Soosten, Laura
    Haar, Janina
    Frehtman, Veronika
    Holderbach, Stefan
    zu Belzen, Julius Upmeier
    Jendrusch, Michael
    Okonechnikov, Konstantin
    Pfister, Stefan M.
    Grimm, Dirk
    Leuchs, Barbara
    Jones, David
    Kutscher, Lena M.
    Zuckermann, Marc
    NEURO-ONCOLOGY, 2022, 24 : 185 - 186
  • [27] Peripapillary Intravitreal Injection Improves AAV-Mediated Retinal Transduction
    Madrakhimov, Sanjar Batirovich
    Yang, Jin Young
    Ahn, Dong Hyuck
    Han, Jung Woo
    Ha, Tae Ho
    Park, Tae Kwann
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 17 : 647 - 656
  • [28] AAV-mediated in vivo genome editing in vascular endothelial cells
    Wu, Wenyi
    Yang, Yanhui
    Yao, Fei
    Dong, Lijun
    Xia, Xiaobo
    Zhang, Shaochong
    Lei, Hetian
    METHODS, 2021, 194 : 12 - 17
  • [29] AAV-mediated gene transfer for treatment of hemophilia
    Wang, LX
    Herzog, RW
    CURRENT GENE THERAPY, 2005, 5 (03) : 349 - 360
  • [30] AAV-mediated gene therapy of Pompe disease
    Ziegler, RJ
    Bercury, S
    Armentaro, D
    Raben, N
    Cheng, SH
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 713 - 713